RT Journal
A1 Chou R, LeFevre ML
T1 PRostate cancer screening—the evidence, the recommendations, and the clinical implications
JF JAMA
JO JAMA
YR 2011
FD December 28
VO 306
IS 24
SP 2721
OP 2722
DO 10.1001/jama.2011.1891
UL http://dx.doi.org/10.1001/jama.2011.1891
AB 
The mission of the USPSTF is to improve the health of all persons in the United States by making evidence-based recommendations about clinical preventive services. Each USPSTF recommendation is based on a systematic review of the evidence.1 Before making a recommendation about a preventive service, the task force requires that the evidence be sufficient to estimate with at least moderate certainty the balance of benefits relative to harms.2 In this case, across the population of screened men, the USPSTF determined that benefits of prostate-specific antigen (PSA)–based screening for prostate cancer were outweighed by harms.